Patents
Patents for C07C 215 - Compounds containing amino and hydroxy groups bound to the same carbon skeleton (11,541)
12/2001
12/06/2001CA2410660A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists
12/05/2001EP1159261A2 Antizyme modulators and their use
12/05/2001EP1159257A1 Esterquats, their intermediates, a process to make the esterquats, and their use
12/05/2001EP1159256A1 Sphingoid base derivatives and uses thereof
12/05/2001EP1159255A2 Bis(1,3-dihydroxy-prop-2-yl)amine and derivatives thereof in the manufacture of polymers
12/05/2001EP1159254A1 Oxyalkylene-substituted aminophenol intermediate
12/05/2001EP1159253A2 Synthesis of nitroalcohol diastereomers
12/04/2001US6326153 Polynucleotide sequencing
12/04/2001CA2195014C Positive photoactive compounds based on 2,6-dinitrobenzyl groups
11/2001
11/29/2001US20010047111 Precipitating or crystallizing a salt from solution; suitable as intermediates for large scale production of enzyme inhibitors, e.g. hydroxyethylamine, hydroxyethylurea and hydroxyethylsulfonamide
11/29/2001US20010047108 Method for making HBED
11/29/2001DE10025238A1 Verwendung substituierter 1-Amino-5-phenylpentan-3-ol- und/oder 1-Amino-6-phenylhexan-3-ol- Verbindungen als Arzneimittel Use of substituted 1-amino-5-phenylpentane-3-ol and / or 1-amino-6-phenylhexane-3-ol compounds as medicaments
11/29/2001DE10024263A1 p-Phenylendiaminderivat-Konzentrat p-phenylenediamine derivative Concentrate
11/28/2001EP1157002A1 1,2,3,4-tetrahydro-1-naphthalenamine compounds useful in therapy
11/28/2001EP0850234B1 Novel heterocyclic compounds for the treatment of pain and use thereof
11/28/2001EP0660716B1 Non-acidic cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents
11/28/2001CN1324338A Methods and compositions for inhibiting polymerization of ethylenically unsaturated hydrocarbons
11/28/2001CN1323794A Novel hetero naphthenic benzcyclobutane and heterocyclo acryl benzcyclobutane compound, their prepn. method and pharmaceutical composites
11/28/2001CN1075489C Process for synthesizing p-amniophenol
11/27/2001US6323371 Process for the preparation of alkanolamines having improved color quality
11/27/2001US6323369 As analgesics
11/22/2001US20010044557 Reacting an alkane and/or alkene with a source of oxygen, a source of nitrogen and, optionally, additional hydrogen for partial oxidative amination to alkanolamine and alkyleneamine
11/21/2001EP1156365A1 A concentrate comprising a p-phenylenediamine derivative
11/21/2001EP1156049A1 Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
11/21/2001EP1154982A2 Low odor choline salts
11/21/2001CN1323289A Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
11/21/2001CN1322711A Prepn of optically active chloromycetin
11/21/2001CN1075055C Process for reducing amino acids and derivatives thereof
11/20/2001US6320084 Process for the preparation of glyceraldehyde and derivatives thereof
11/20/2001US6320052 Crystalline precursors of 1-(((1(r)-(3-(2-(7-chloro-2-quino lynyl)ethenyl)phenyl)-3-(2-hydroxy-1-methyl-ethyl)phenyl) propyl)thio)methyl)cyclopropylacetic acid
11/15/2001WO2001085668A1 Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
11/15/2001WO2001008672A3 Glucamine compounds for treating hepatitis virus infections
11/14/2001EP0975581B1 Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine choline tartrate
11/14/2001CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001CN1321633A Synthesis of substd amine
11/13/2001US6316671 Method for splitting 1-amino-alkan-2-ol compounds
11/08/2001WO2001084234A1 Method for immobilizing oligonucleotides employing the cycloaddition bioconjugation method
11/08/2001WO2000017133A3 Lta4 hydrolase inhibitors
11/08/2001US20010039295 Transfusional iron overload
11/08/2001EP1144348A3 Lta 4? hydrolase inhibitors
11/07/2001CN1321160A Process for preparation of N-(phosphonomethyl)glycine by oxidizing N-substd N-(phosphonomethyl)glycine
11/07/2001CN1074410C Process for preparation of 4,6-diaminoresorcinol
11/06/2001US6313349 Electroluminescent intermediate
11/06/2001US6313163 Administering 2,4-pentadienoic acid derivative for therapy of disease or condition responsive to therapy by retinoids
11/06/2001US6313146 Calcium receptor-active molecules
11/06/2001US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use
11/01/2001WO2001081295A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
11/01/2001CA2406272A1 Cyclohexylamine derivative as subtype selective nmda receptor antagonists
10/2001
10/31/2001EP1149843A1 Substituted phenethylamine derivatives
10/31/2001EP0944579B1 Aminohydrofluorides and their use as oral hygiene preparations
10/31/2001CN1073984C A process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronapht-halene derivatives
10/31/2001CN1073983C Method for synthesis of beta-adrenomimetic excitant type fodder additive
10/30/2001US6310254 Reducing an optically active amino acid with hydrogen in the presence of a ruthenium-containing catalyst and an organic or inorganic acid other than said optically active amino acid to obtain optically active amino alcohol
10/30/2001US6310248 Process and intermediates
10/30/2001US6310103 Administering to a mammal suffering from urinary incontinence incontinence while reducing adverse effect associted with racemic or r-enantiiomer of tolterodine, a s(-)-2-(alpha-(2-(diisopropylamino)ethyl)benzyl)-p-cresol
10/30/2001US6310087 Treating gastric or duodenal ulcer, osteoporosis, constipation, renal disorders, sexual dysfunction, baldness, diabetes, cancer and disorder of immune regulation
10/30/2001US6310060 For use as antiproliferative agent for use against cancer, psoriasis, restenosis, autoimmune disease, or atherosclerosis
10/25/2001WO2001079244A1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
10/25/2001WO2001079152A1 Sphingolipids
10/25/2001US20010034464 Reduction of carbonyl compounds by a silane in the presence of a zinc catalyst
10/25/2001US20010034409 Mannich bases and further compounds based on alkyldipropylenetriamines
10/24/2001EP1147075A1 Method for producing l-phenylephrine hydrochloride
10/24/2001CN1318538A Method of extracting octaverine from Chinese medicine material immature bitter orange
10/24/2001CN1318536A Substituted biphenyl oxazoline
10/23/2001US6306179 Method for the synthesis of 2-hydroxyalkyl-para-phenylenediamines, new 2-hydroxyalkyl-para-phenylenediamines, their use for oxidation dyeing, dyeing compositions and methods of dyeing
10/23/2001CA2222657C Intermediates in preparation of new phenylethanolaminomethyltetralins
10/23/2001CA2040058C Alpha-mannosidase and fucosidase inhibitors
10/18/2001US20010031897 Reating with phosphorous acid or hypophosphorous acid or compounds thereof, at high temperature for at least 5 minutes, and then distilling in the presence of one of these phosphorus compounds
10/17/2001EP1146041A1 Derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane and their use as inhibitors of the recapture of serotonine and of noradrenaline
10/17/2001EP1144358A2 Process for production of 2-amino-1,3-propanediol
10/17/2001EP1144348A2 Lta 4? hydrolase inhibitors
10/17/2001EP1143964A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
10/17/2001CN1317480A One-step process for synthetizing 2-oxazolidone derivative
10/17/2001CN1073085C Process for prepn. O-desmethyl tramadol antimer
10/11/2001DE10014855A1 Novel p-diaminobenzene derivatives used as developers in hair dyes
10/10/2001EP1142865A1 Novel 1,2-diphenyl-2-propen-1-one derivatives
10/10/2001EP1142864A1 Process for producing l-erythro-(1r,2s)-2-amino-1-phenylpropan-1-ol
10/10/2001EP1140849A1 Aminoalcohol derivatives and their use as beta 3 adrenergic agonists
10/10/2001EP1140808A1 Pesticide formulations containing alkoxylated tristyrylphenol hemi-sulfate ester neutralized alkoxylated amine surfactants
10/10/2001EP1140790A1 Novel oxo-aminotetralin compounds useful in pain management
10/10/2001EP1140789A1 Method for purifying triethanolamine
10/10/2001EP1019318B1 Method and composition for the regeneration of an aminal compound
10/10/2001EP0840731B1 Polycyclic alcaloid-derivatives as nmda-receptor antagonists
10/09/2001US6300376 Indane dimer compounds and their pharmaceutical use
10/09/2001US6300323 (Poly)ethereal ammonium salts of herbicides bearing acidic moieties and their use as herbicides
10/04/2001WO2001072869A2 Mannich bases and further compounds based on alkyldipropylenetriamines as hardeners for epoxy resins
10/04/2001WO2001072686A1 P-diaminobenzene derivatives and dyes containing said compounds
10/04/2001WO2001072669A2 Therapeutic use of polyhydroxy amine derivates
10/04/2001EP1017666A4 Process for enhancing the optical purity of 2r- 1-hydroxy- 1-trifluoromethyl- 3-cyclopropylpropyn-2yl] -4-chloroaniline
10/04/2001DE10014655A1 Alkyldipropylenetriamine-based Mannich bases and adducts and their reaction products with epoxides are useful as low viscosity hardeners for e.g. epoxy coatings to give rapid hardening at low temperature and high humidity
10/04/2001CA2402454A1 Mannich bases and further compounds based on alkyldipropylenetriamines as hardeners for epoxy resins
10/03/2001CN1315945A Nitrate salts of antihypertensive medicines
10/03/2001CN1315318A Process for synthesizing phenylethanolamine additive of feed
10/02/2001US6297401 A 3-nitrosalicylamide derivative effective against plant pytopathogens
10/02/2001US6297399 Hypotensive agents
10/02/2001CA2250092C Triaryl and diaryl compounds, their analogues and uses thereof
09/2001
09/27/2001US20010025124 Dissolving 3-butene-1,2-diol in alkanol; ozonolysis
09/26/2001EP1136470A1 Process for the preparation of a piperazine derivative
09/26/2001EP1135360A1 Novel 3-alkoxybenzylamine derivatives and their use as medicines for treating schizophrenia
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 116